Carregant...

Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia

Half of the patients with acute myeloid leukemia (AML), who achieve complete remission after chemotherapy treatment, will ultimately experience a relapse. Measurable residual disease (MRD) is an important post‐treatment risk factor in AML, because it gives additional information about the depth of t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Protoc Cytom
Autors principals: Zeijlemaker, Wendelien, Kelder, Angele, Cloos, Jacqueline, Schuurhuis, Gerrit Jan
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856793/
https://ncbi.nlm.nih.gov/pubmed/31763792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpcy.66
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!